Keywords: مزوتلیوما; Mesothelioma; vasculogenic mimicry; angiogenesis; VEGF; CD31; mesothelial markers;
مقالات ISI مزوتلیوما (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مزوتلیوما; Mesothelioma; Axitinib; VEGF; Angiogenesis, Phase II; Translational research;
Keywords: مزوتلیوما; Mesothelioma; Pleura; Targeted therapy; Resistance
Keywords: مزوتلیوما; Mesothelioma; Prognosis; Decision trees; Survival;
Keywords: مزوتلیوما; Pediatric; Mesothelioma; Malignancy
Keywords: مزوتلیوما; Mesothelioma; Survival; Audit; Chemotherapy; Surgery; Performance status; Stage;
Keywords: مزوتلیوما; Mesothelioma; Lung adenocarcinoma; Claudins; Diagnosis; Therapeutic target
Keywords: مزوتلیوما; Chloride; Gene expression; Ion Channel; Mesothelioma; Transcitpromics
Keywords: مزوتلیوما; Mesothelioma; Reoperation; Cytoreductive surgery; Survival; Mortality; Morbidity;
Keywords: مزوتلیوما; Mesothelioma; Mortality; Asbestos; Brazil;
Keywords: مزوتلیوما; Mesothelioma; Miliary pulmonary metastases; Nephrotic syndrome;
Keywords: مزوتلیوما; Mesothelioma; James Lind Alliance; Priority Setting Partnership; Patient involvement; Research Priorities; Interventions;
Keywords: مزوتلیوما; Mesothelioma; Pre-clinical imaging; F-MISO; PET/CT; Tumor hypoxia; Diffusion-weighted MRI; Apparent diffusion coefficient; Tumor histology; Tumor response assessment; Tumor volume; Tumor response criteria; Tumor volume growth rate;
Keywords: مزوتلیوما; Reactive mesothelial proliferation; Atypical mesothelial proliferation; Mesothelioma; Desmin; Epithelial membrane antigen (EMA); Serum mesothelin related peptide (SMRP)
Keywords: مزوتلیوما; Mesothelioma; Gene expression; Cancer genes; Biomarkers; Therapeutic targets
Keywords: مزوتلیوما; MM; malignant mesothelioma; LC; lung cancer; SMRPs; soluble mesothelin-related proteins; miR-126; microRNA-126; Met-TM; methylated thrombomodulin; TM; thrombomodulin; EGFL7; EGF-like-domain, multiple 7; ROC; Receiver operating characteristics; AUC; area u
Keywords: مزوتلیوما; Asbestos; Mesothelioma; Cancer incidence; Occupational exposure; Familial exposure; Environmental exposure;
Keywords: مزوتلیوما; Mesothelioma; SEER; Epithelioid; Sarcomatoid; Biphasic; Fibrous; Surgery
Keywords: مزوتلیوما; Connexin; Mesothelioma; Chemotherapy; Sunitinib; Drug resistance
Keywords: مزوتلیوما; 9; 10; mesothelioma; spheroids; nanoparticle; paclitaxel; 2-D; 2 dimensional; 3-D; 3 dimensional; eNP; expansile nanoparticle; OG-Pax; expansile nanoparticles loaded with standard paclitaxel doped with Oregon Green 488 conjugated paclitaxel; Pax-C/e; pacl
Keywords: مزوتلیوما; Immunotherapy; Programmed death-1; Cytotoxic T-lymphocyte antigen-4; Mesothelioma; Immune checkpoint;
Keywords: مزوتلیوما; Biomarcadores; derrame pleural maligno; mesotelioma; pleurodesis; toracoscopia.Biomarkers; malignant pleural effusion; mesothelioma; pleurodesis; thoracoscopy.
Keywords: مزوتلیوما; Pleura; Mesothelioma; Metastatic disease; Pleural effusion; Solitary fibrous tumor; Molecular biology;
Keywords: مزوتلیوما; Mesothelioma; Treatment; Chemotherapy; Second line; Biological; Targeted treatment; Outcome; Meta-analysis;
Keywords: مزوتلیوما; Hernia sac; Mesothelioma; Peritoneum; Well-differentiated papillary mesothelioma
Keywords: مزوتلیوما; Mesothelioma; Epithelioid; Sarcomatoid; Systematic review; Response rates; Tumor;
Keywords: مزوتلیوما; Mesothelioma; CABG; Pleura; Pneumonectomy; Trimodality therapy
Keywords: مزوتلیوما; Pain; Radiotherapy; Treatment; Malignant; Pleural; Mesothelioma;
Keywords: مزوتلیوما; Gene amplification; Gene alteration; Mesothelioma; Mutation; Phosphatidylinositol 3-kinases; VHL tumor suppressor;
Keywords: مزوتلیوما; Asbestos; Risk assessment; Environmental exposure; Lung cancer; Mesothelioma; Province of Quebec
Keywords: مزوتلیوما; Mesothelioma; Education; Nurse; RCT; Knowledge; Attitude; Difficulty;
Keywords: مزوتلیوما; Mesothelioma; Bayesian prediction; Cohort analysis; Asbestos; Occupational exposure; Incidence; Public health;
Keywords: مزوتلیوما; Asbestos; Chrysotile; Electricians; Exposure; Lung cancer; Mesothelioma; Occupational; Review;
Keywords: مزوتلیوما; Mesothelioma; Breast carcinoma; Triple-negative breast carcinoma; Immunohistochemistry; Calretinin; Mesothelin; GATA3
Keywords: مزوتلیوما; Mesothelioma; Meta-analysis; Pneumonectomy; Pleurectomy; Systematic review; Surgery;
Keywords: مزوتلیوما; Hyaluronic acid; Asbestos; Mesothelioma; Pleural fluid;
Keywords: مزوتلیوما; Asbestos; Chrysotile; Mesothelioma; Lung cancer;
Keywords: مزوتلیوما; Mesothelioma; Hyaluronic acid; Mesothelin; Pleural effusion; Diagnosis;
Keywords: مزوتلیوما; Genetics; Genome-wide association study; Case-control studies; Mesothelioma; Asbestos;
Keywords: مزوتلیوما; Migration; Proliferation; Cytokinesis; Melanoma; Mesothelioma; Lung cancer;
Keywords: مزوتلیوما; Gamma tocotrienol; Statin; Mesothelioma; Mevalonate pathway; Apoptosis;
Keywords: مزوتلیوما; Mesenteric cyst; Laparotomy; Ovary; CT; Mesothelioma
Keywords: مزوتلیوما; Mesothelioma; Wnt; Secreted frizzled-related protein 4; Metabolism
Keywords: مزوتلیوما; Mesothelioma; Nanoparticle; Drug delivery; Paclitaxel; Autophagosome; Tumor localization
Keywords: مزوتلیوما; Mesothelioma; Asbestos; Incidence; Survival; Occupational health; Ireland
Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications
Keywords: مزوتلیوما; BRCA1-associated protein1; BAP1; mesothelin; PD-L1; mesothelioma; overall survival;
WWW mesothelioma information: Surfing on unreliable waters. A cross-sectional study into the content and quality of online informational resources for mesothelioma patients
Keywords: مزوتلیوما; Mesothelioma; Patient information; Online information; Decision-making;
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma
Keywords: مزوتلیوما; Mesothelioma; Immunotherapy; Programmed death ligand 1; Nivolumab; Checkpoint inhibitor;
Uptake-release by MSCs of a cationic platinum(II) complex active in vitro on human malignant cancer cell lines
Keywords: مزوتلیوما; MPM; malignant pleural mesothelioma; GBM; glioblastoma multiforme; PAC; pancreatic adenocarcinoma; GCB; gemcitabine; CisPt; cisplatin; MSCs; mesenchymal stromal cells; caPt(II)-complex; cationic platinum(II) complex; CFPAC-1; pancreatic carcinoma cell lin
Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma
Keywords: مزوتلیوما; Uveal melanoma; Mesothelioma; Renal cell carcinoma; BAP1 cancer predisposition syndrome; BRCA1-associated protein-1; BAP1;